Interviews

Download PDF

Register to download the report. Already a member?

 
 
Sign Up

Or

63850 1504871583HCLSReviewHongKongSeptember2017.pdf
Energy Boardroom

Pharma Interviews


Filter

Interview: Ridha Charfeddine – CEO, Unimed & President, National Chamber of the Pharmaceutical Industry (CNIP), Tunisia

Ridha Charfeddine, founding CEO of Unimed and president of the National Chamber of the Pharmaceutical Industry (CNIP) discusses enforcing European quality standards in Tunisia, the CNIP’s role in guiding pharmaceutical and medical device companies in Tunisia, as well as his …

19.10.2017

Interview: Urszula Orzel – General Manager, MSD Bulgaria

Urszula Orzel, general manager at MSD Bulgaria, explains how the affiliate has become one of the fastest growing players in the country and emphasizes that pharmaceutical companies are not merely manufacturers of drugs, but should also be socially committed. This …

18.10.2017


Interview: Ramzi Lebbi – General Manager, mc PHARMA, Tunisia

Ramzi Lebbi, general director and co-founder of mc PHARMA, a Tunisian medical information and promotion agency, describes the company’s evolution since its foundation 15 years ago, its service provider activities for multinational companies, and the potential expansion of its portfolio …

18.10.2017

Interview: Ali Achouri – Founder and CEO, Generika, Tunisia

Ali Achouri of Laboratoires Generika in Tunisia discusses his success story, his attentiveness to the satisfaction of its customers, the importance of geographical and cultural proximity with pharmaceutical companies in Maghreb, and how Generika will soon offer its services for …

17.10.2017


Interview: Thierry Mauvernay – President and Delegate of the Board, Debiopharm, Switzerland

Thierry Mauvernay, president and delegate of the board of Debiopharm, discusses the Swiss Group’s development over its 38 years of history, its unique business strategy, and how new trends such as personalized medicine and digitalization are being embraced moving forward. …

17.10.2017

Interview: Barbara Rangetiner – General Manager; Josef Weinberger – Corporate Quality and Compliance Officer, Octapharma Austria

Barbara Rangetiner and Josef Weinberger of the Austrian affiliate of Octapharma, the largest privately owned human protein products manufacturer in the world, discuss the strategic significance of Austria to the group, the nation’s historical excellence in plasma and hematology, and …

17.10.2017


Interview: Walid Lakhdar – Country Business Unit Head, Pfizer Tunisia and Libya

Walid Lakhdar, country business unit head for Tunisia and Libya at Pfizer, stresses the company’s ongoing dedication to patients in Tunisia. This was illustrated by the significant investments Pfizer has made in Tunisia after the revolution and still continues to …

17.10.2017

Interview: Wolfgang Harrer – Regional Manager, Chiesi Central and Eastern Europe

Dr. Wolfgang Harrer, regional manager of Chiesi Central and Eastern Europe (CEE), discusses the challenges of managing the region’s diverse cultural differences and the importance of CEE within global operations. Furthermore, he points out the factors influencing the influx of …

17.10.2017


Interview: Giacomo Di Nepi – CEO, Polyphor, Switzerland

Giacomo Di Nepi, CEO of innovative Swiss specialty pharma outfit Polyphor, discusses his decision to join the company in 2016, his main priorities, and the potential impact of an IPO in the next two years. Having previously held senior leadership …

16.10.2017

Interview: Kamen Plochev – Governor, National Health Insurance Fund (NHIF), Bulgaria

Prof. Dr. Kamen Plochev, Dr. M. Sc., recently appointed as the governor of the National Health Insurance Fund in Bulgaria, discusses the key issues he has identified for the Bulgarian healthcare system as well as how he intends to tackle …

16.10.2017


Interview: David Kasper – CEO, ARCHIMEDlife, Austria

David Kasper, CEO of ARCHIMEDlife, an innovative Austrian company focused on novel laboratory diagnostics, discusses the innovative solution of a dried blood sample in daily routine diagnostics and novel assays as well as the intricacies of working in rare diseases. …

16.10.2017

Interview: Andrew Casey – President and CEO, BIOTECanada

Andrew Casey, President and CEO of BIOTECanada, the national biotech association, provides an update on the Canadian biotech landscape, the strength of the Canadian R&D ecosystem, the growing investor community (both Canadian and foreign) looking to Canada as an untapped …

16.10.2017


LATEST ISSUE

DOWNLOAD

Most Read

X
Download PDF

First Name:

Last Name:

Company:

Position:

Country:

Email: